SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Martek Biosciences---- future biotech cash cow!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Machaon who wrote (118)1/7/1998 2:37:00 AM
From: scaram(o)uche  Read Replies (1) of 258
 
I agree, all published data indicates that DHA should be in formula.

However, if you walk into any GNC, you'll see the MATK product together with others. As a matter of fact, the MATK product was the second to hit the shelves at GNC, and I've seen at least one report of another algae-derived DHA. It appears that MATK doesn't have a lock on patents that exclude competitors from the nutriceutical market? So...... what's to stop competitors from making this a commodity product? Can someone please summarize the patent status for us? Good product, lousy business plan?

Thanks, Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News